Board Meeting on Feb 27, 2012
Venus Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 27, 2012, inter alia, to consider and approve issue and allotment of equity shares on conversion of fully convertible warrants to promoter group Company on a preferential basis. Venus Remedies to enter Japan market with patent approval for its novel research product 'Vancoplus'
Venus Remedies Ltd has informed BSE regarding "Venus Remedies to enter Japan market with patent approval for its novel research product 'Vancoplus'.Announcement:"The Company has achieved another landmark by fetching its first patent grant from Japan patent office (JPO) which is among the most stringent Pharma markets in the world. This patent has been granted for its novel research product 'Vancoplus' which has been designed to curb... Financial Results & Limited Review for Dec 31, 2011
Venus Remedies Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011. Outcome of Board Meeting
Venus Remedies Ltd has informed BSE that the Board Of Directors of the Company at its meeting held on December 21, 2011, inter alia, has issued and allotted 17,00,000 fully convertible warrants on a preferential basis to Sunev Pharma Solutions Ltd., a promoter group company. Emerging Company of the year 2011
Venus Remedies Ltd has informed BSE regarding "Emerging Company of the year 2011, Venus Remedies Limited"Announcement:"This is to inform that Company has emerged as a winner of 'Emerging Company of the Year 2011' award in the 4th annual Pharmaceutical Leadership Summit & Award 2011. The event was organised at the Hotel Lalit Plaza, Intercontinental on 10th December, 2011.... Board Meeting on Dec 21, 2011
Venus Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 21, 2011, inter alia, to consider allotment of 17,00,000 warrants fully convertible into equity shares to promoter group Company on a preferential basis. Venus Remedies wins "India Manufacturing Excellence Award 2011
Venus Remedies Ltd has informed BSE regarding "Venus Remedies wins "India Manufacturing Excellence Award 2011"Announcement:"Company has emerged as a winner of 'Silver Certificate of Merit' in the Economic Times' India Manufacturing Excellence Awards (IMEA), 2011 held in Mumbai. The Company has bagged this award for its Baddi unit, based on the assessments conducted at the site and whetted by the jury of Economic Times' IMEA 2011 in partnership with Frost & Sullivan.... Venus Remedies receives Market Authorisation for Meropenem in UK & New Zealand
Venus Remedies Ltd has informed BSE regarding "Venus Remedies receives Market Authorisation for Meropenem in UK & New Zealand"Announcement:"The company has received approval for Market Authorisation from MHRA (UK) via DCP route (which covers Ireland, Poland, Slovenia, Netherlands, Finland, Austria, Slovakia, Denmark, Germany, Sweden, France and Italy also) for its generic broad spectrum injectable antibiotic carbapenem. The company... Financial Results for Sep 30, 2011
Venus Remedies Ltd has informed BSE about the Financial Results for the period ended September 30, 2011. Pharmexcil felicitates Venus Remedies with "Patent Award" in Gold category
Venus Remedies Ltd has informed BSE that Pharmexcil felicitates Venus Remedies with "Patent Award" in Gold category.Announcement:"The Company has won "Patent Award" in Gold category for the year 2010-11 in the valedictory function of India-LAC Pharma Meet by Pharmexcil (Pharmaceuticals Export Promotion Council) held at Hotel Taj Krishna, Hyderabad on September 30, 2011. Hon'able Chief Minister of Andhra Pradesh Mr. N. Kiran Kumar Reddy presented the award....